Atossa Therapeutics Reports Q2 2026 Financial Results

What Happened
On August 7, 2026, Atossa Therapeutics, Inc. announced its financial results for the second quarter ended June 30, 2026 and provided a company update via a press release. The press release is attached to the Form 8‑K as Exhibit 99.1 and is incorporated by reference into the report. The company furnished (but did not “file”) this information, meaning it is not subject to certain liabilities under the Exchange Act and Securities Act.

Key Details

• Date of announcement: August 7, 2026
• Reporting period: Quarter ended June 30, 2026
• Exhibit: Press release attached as Exhibit 99.1 to the Form 8‑K
• Legal note: Information in Items 2.02 and 9.01 (including Exhibit 99.1) was furnished, not filed, and thus is not subject to Section 18 liability or Sections 11 and 12(a)(2) of the Securities Act

Why It Matters
This filing signals that Atossa has reported its latest quarterly operating and financial results and provided operational updates for investors. Retail investors should read the attached press release for the specific financial figures (revenue, net income/loss, cash position, and any guidance or milestones) and any management commentary about business progress. Also note the information was furnished rather than filed, which affects legal liability for the statements in the release.